Award
National Cancer Institute 11527227
Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)
Recipient
UNIVERSITY OF TEXAS DALLAS
Award Amount
$141,522.00
Ceiling
$141,522.00
Awarded
May 12, 2026
Identifier
11527227
NIH grant awarded to study BET inhibitors for Solitary fibrous tumor, including lab studies and clinical trial potential.
Description
This is a NIH grant project focusing on evaluating BET inhibitors for Solitary fibrous tumor (SFT). The project involves in vitro and in vivo studies, molecular mechanism analysis, and potential clinical trial initiation.